Author

Wenhong Zhang

Fudan UniversityORCID 0000-0002-8850-5235Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Wenhong Zhang7 papers · Shanghai Medical College of Fudan University

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Chao QiuiD· 1 shared Cuiyuan Guo· 1 shared Fahui Dai· 1 shared Jiaojiao ZhengiD· 1 shared Jiasheng LuiD· 1 shared Kunlu Deng· 1 shared Wanhai WangiD· 1 shared Xiaoyang ChengiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Chao QiuORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MicrobiologySignal Transduction and Targeted TherapyPeer-reviewedApr 10, 2025

Novel derivatives of BCV and (S)-HPMPA inhibit orthopoxviruses and human adenoviruses more potently than BCV

Yifan Zhang, Yanmin Wan, Cuiyuan Guo…·Wenhong Zhang

This study evaluates novel prodrugs based on (S)-HPMPA and (S)-HPMPC, finding that ODE-(S)-HPMPA formate is more potent against orthopoxviruses and adenoviruses than BCV, but less effective against HSV-1.

16 citationstop 3%

humanexperimental assay

𝕏 PostBluesky